BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Luo W, Fedda F, Lynch P, Tan D. CDH1 Gene and Hereditary Diffuse Gastric Cancer Syndrome: Molecular and Histological Alterations and Implications for Diagnosis And Treatment. Front Pharmacol. 2018;9:1421. [PMID: 30568591 DOI: 10.3389/fphar.2018.01421] [Cited by in Crossref: 23] [Cited by in F6Publishing: 27] [Article Influence: 5.8] [Reference Citation Analysis]
Number Citing Articles
1 Benesch MGK, Mathieson A. Epidemiology of Signet Ring Cell Adenocarcinomas. Cancers (Basel) 2020;12:E1544. [PMID: 32545410 DOI: 10.3390/cancers12061544] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
2 Yin X, Fang T, Wang Y, Wang Y, Zhang D, Li C, Xue Y. Prognostic significance of serum inflammation indexes in different Lauren classification of gastric cancer. Cancer Med 2021;10:1103-19. [PMID: 33410261 DOI: 10.1002/cam4.3706] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Westhoff CC, Jank P, Jacke CO, Albert US, Ebrahimsade S, Barth PJ, Moll R. Prognostic relevance of the loss of stromal CD34 positive fibroblasts in invasive lobular carcinoma of the breast. Virchows Arch 2020;477:717-24. [PMID: 32435886 DOI: 10.1007/s00428-020-02835-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
4 Balmagambetova SK, Bekmukhambetov YZ, Tulyaeva AB, Iztleuov YM, Smagulova GA, Koyshybaev AK, Urazayev ON, Djussembekov ST, Begunov VV, Kokhreidze I. Gastric Cancer in Aktobe Region of Western Kazakhstan from 2009 to 2018: Incidence Rates, Trends, and Five-Year Survival. Asian Pac J Cancer Prev 2020;21:1645-52. [PMID: 32592359 DOI: 10.31557/APJCP.2020.21.6.1645] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Rohr M, Aljabban J, Rudeski-Rohr T, Lessans S, Nakkina SP, Hadley D, Zhu X, Altomare DA. Meta-Analysis Reveals the Prognostic Relevance of Nuclear and Membrane-Associated Bile Acid Receptors in Gastric Cancer. Clin Transl Gastroenterol 2021;12:e00295. [PMID: 33492921 DOI: 10.14309/ctg.0000000000000295] [Reference Citation Analysis]
6 Hirakawa M, Takada K, Sato M, Fujita C, Hayasaka N, Nobuoka T, Sugita S, Ishikawa A, Mizukami M, Ohnuma H, Murase K, Miyanishi K, Kobune M, Takemasa I, Hasegawa T, Sakurai A, Kato J. Case series of three patients with hereditary diffuse gastric cancer in a single family: Three case reports and review of literature. World J Gastroenterol 2020; 26(42): 6689-6697 [PMID: 33268956 DOI: 10.3748/wjg.v26.i42.6689] [Reference Citation Analysis]
7 Tsugeno Y, Nakano K, Nakajima T, Namikawa K, Takamatsu M, Yamamoto N, Fujisaki J, Nunobe S, Kitagawa M, Takeuchi K, Kawachi H. Histopathologic Analysis of Signet-ring Cell Carcinoma In Situ in Patients With Hereditary Diffuse Gastric Cancer. Am J Surg Pathol 2020;44:1204-12. [PMID: 32520759 DOI: 10.1097/PAS.0000000000001511] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
8 Kumar S, Long JM, Ginsberg GG, Katona BW. The role of endoscopy in the management of hereditary diffuse gastric cancer syndrome. World J Gastroenterol 2019; 25(23): 2878-2886 [PMID: 31249446 DOI: 10.3748/wjg.v25.i23.2878] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 20] [Article Influence: 5.3] [Reference Citation Analysis]
9 Xing X, Jia S, Leng Y, Wang Q, Li Z, Dong B, Guo T, Cheng X, Du H, Hu Y, Feng Q, Lian S, Luan F, Ma X, Li Z, Ni M, Li Z, Ji J. An integrated classifier improves prognostic accuracy in non-metastatic gastric cancer. Oncoimmunology 2020;9:1792038. [PMID: 32939321 DOI: 10.1080/2162402X.2020.1792038] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
10 Iyer P, Moslim M, Farma JM, Denlinger CS. Diffuse gastric cancer: histologic, molecular, and genetic basis of disease. Transl Gastroenterol Hepatol 2020;5:52. [PMID: 33073047 DOI: 10.21037/tgh.2020.01.02] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
11 Goud HK, Mehkari Z, Mohammed L, Javed M, Althwanay A, Ahsan F, Oliveri F, Rutkofsky IH. Significance of E-cadherin Gene Mutations in Patients With Hereditary Diffuse Gastric Cancer Syndrome: A Systematic Review. Cureus 2020;12:e10406. [PMID: 33062523 DOI: 10.7759/cureus.10406] [Reference Citation Analysis]
12 Decourtye-Espiard L, Bougen-Zhukov N, Godwin T, Brew T, Schulpen E, Black MA, Guilford P. E-Cadherin-Deficient Epithelial Cells Are Sensitive to HDAC Inhibitors. Cancers (Basel) 2021;14:175. [PMID: 35008338 DOI: 10.3390/cancers14010175] [Reference Citation Analysis]
13 Taja-Chayeb L, Vidal-Millán S, Trejo-Becerril C, Pérez-Cárdenas E, Chávez-Blanco A, Domínguez-Gómez G, González-Fierro A, Romo-Pérez A, Dueñas-González A. Hereditary Diffuse Gastric Cancer (HDGC). An overview. Clin Res Hepatol Gastroenterol 2021;:101820. [PMID: 34656755 DOI: 10.1016/j.clinre.2021.101820] [Reference Citation Analysis]
14 Benesch MGK, Bursey SR, O'Connell AC, Ryan MG, Howard CL, Stockley CC, Mathieson A. CDH1 Gene Mutation Hereditary Diffuse Gastric Cancer Outcomes: Analysis of a Large Cohort, Systematic Review of Endoscopic Surveillance, and Secondary Cancer Risk Postulation. Cancers (Basel) 2021;13:2622. [PMID: 34073553 DOI: 10.3390/cancers13112622] [Reference Citation Analysis]
15 Dvorská D, Braný D, Nagy B, Grendár M, Poka R, Soltész B, Jagelková M, Zelinová K, Lasabová Z, Zubor P, Danková Z. Aberrant Methylation Status of Tumour Suppressor Genes in Ovarian Cancer Tissue and Paired Plasma Samples. Int J Mol Sci 2019;20:E4119. [PMID: 31450846 DOI: 10.3390/ijms20174119] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
16 Machlowska J, Baj J, Sitarz M, Maciejewski R, Sitarz R. Gastric Cancer: Epidemiology, Risk Factors, Classification, Genomic Characteristics and Treatment Strategies. Int J Mol Sci. 2020;21. [PMID: 32512697 DOI: 10.3390/ijms21114012] [Cited by in Crossref: 37] [Cited by in F6Publishing: 42] [Article Influence: 18.5] [Reference Citation Analysis]
17 Jang HJ, Lee A, Kang J, Song IH, Lee SH. Prediction of genetic alterations from gastric cancer histopathology images using a fully automated deep learning approach. World J Gastroenterol 2021; 27(44): 7687-7704 [PMID: 34908807 DOI: 10.3748/wjg.v27.i44.7687] [Reference Citation Analysis]
18 Assumpção P, Araújo T, Khayat A, Ishak G, Santos S, Barra W, Acioli JF, Rossi B, Assumpção P. Hereditary gastric cancer: Three rules to reduce missed diagnoses. World J Gastroenterol 2020; 26(13): 1382-1393 [PMID: 32308342 DOI: 10.3748/wjg.v26.i13.1382] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
19 He YL, Zhang B. Clinical significance of expression of CBX2 in gastric cancer. Shijie Huaren Xiaohua Zazhi 2019; 27(14): 872-877 [DOI: 10.11569/wcjd.v27.i14.872] [Reference Citation Analysis]
20 Hu MN, Hu SH, Zhang XW, Xiong SM, Deng H. Overview on new progress of hereditary diffuse gastric cancer with CDH1 variants. Tumori 2020;106:346-55. [PMID: 32811340 DOI: 10.1177/0300891620949668] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
21 Businello G, Angerilli V, Parente P, Realdon S, Savarino E, Farinati F, Grillo F, Vanoli A, Galuppini F, Paccagnella S, Pennelli G, Mastracci L, Saragoni L, Fassan M. Molecular Landscapes of Gastric Pre-Neoplastic and Pre-Invasive Lesions. Int J Mol Sci 2021;22:9950. [PMID: 34576114 DOI: 10.3390/ijms22189950] [Reference Citation Analysis]
22 Sexton RE, Hallak MNA, Uddin MH, Diab M, Azmi AS. Gastric Cancer Heterogeneity and Clinical Outcomes. Technol Cancer Res Treat 2020;19:1533033820935477. [PMID: 32799763 DOI: 10.1177/1533033820935477] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
23 Nemtsova MV, Kalinkin AI, Kuznetsova EB, Bure IV, Alekseeva EA, Bykov II, Khorobrykh TV, Mikhaylenko DS, Tanas AS, Kutsev SI, Zaletaev DV, Strelnikov VV. Clinical relevance of somatic mutations in main driver genes detected in gastric cancer patients by next-generation DNA sequencing. Sci Rep 2020;10:504. [PMID: 31949278 DOI: 10.1038/s41598-020-57544-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
24 Lu J, Jin M, Zhou X, Chen X, Shao Y, Jiang X. Clinicopathological and molecular characteristics of the alpha-fetoprotein-producing gastric cancer: emphasis on two major subtypes. APMIS 2021. [PMID: 34862662 DOI: 10.1111/apm.13196] [Reference Citation Analysis]
25 Nolen LD, Bressler S, Vindigni SM, Miller K, Nash S. Gastric Cancer in Alaska Native and American Indian People Living in Alaska, 1990-2017. Clin Transl Gastroenterol 2021;12:e00374. [PMID: 34158461 DOI: 10.14309/ctg.0000000000000374] [Reference Citation Analysis]
26 Zhao Z, Li S, Li S, Wang J, Lin H, Fu W. High expression of oncogene cadherin-6 correlates with tumor progression and a poor prognosis in gastric cancer. Cancer Cell Int 2021;21:493. [PMID: 34530820 DOI: 10.1186/s12935-021-02071-y] [Reference Citation Analysis]
27 Li X, Liu J, Wang K, Zhou J, Zhang H, Zhang M, Shi Y. Polymorphisms and rare variants identified by next-generation sequencing confer risk for lung cancer in han Chinese population. Pathol Res Pract 2020;216:152873. [PMID: 32107087 DOI: 10.1016/j.prp.2020.152873] [Reference Citation Analysis]
28 Arunachalam A, Lakshmanan DK, Ravichandran G, Paul S, Manickam S, Kumar PV, Thilagar S. Regulatory mechanisms of heme regulatory protein BACH1: a potential therapeutic target for cancer. Med Oncol 2021;38:122. [PMID: 34482423 DOI: 10.1007/s12032-021-01573-z] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Zhang Q, Yang Z, Karamchandani DM. Complete histopathologic examination of risk reduction gastrectomy specimens for CDH1 germline mutation: Is it warranted in routine clinical practice? Ann Diagn Pathol 2020;45:151473. [PMID: 31986421 DOI: 10.1016/j.anndiagpath.2020.151473] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Marghalani AM, Bin Salman TO, Faqeeh FJ, Asiri MK, Kabel AM. Gastric carcinoma: Insights into risk factors, methods of diagnosis, possible lines of management, and the role of primary care. J Family Med Prim Care 2020;9:2659-63. [PMID: 32984103 DOI: 10.4103/jfmpc.jfmpc_527_20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
31 Zarrilli G, Galuppini F, Angerilli V, Munari G, Sabbadin M, Lazzarin V, Nicolè L, Biancotti R, Fassan M. miRNAs Involved in Esophageal Carcinogenesis and miRNA-Related Therapeutic Perspectives in Esophageal Carcinoma. Int J Mol Sci 2021;22:3640. [PMID: 33807389 DOI: 10.3390/ijms22073640] [Reference Citation Analysis]